Project Details
Description
A 24-WEEK, OPEN-LABEL, RANDOMIZED, 2-ARM STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF KRX-0502 (FERRIC CITRATE) IN CHILDREN WITH IRON DEFICIENCY ANEMIA ASSOCIATED WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/21 → 12/31/25 |
Funding
- AKEBIA THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.